| [1] |
Villafuerte FC, Corante N. Chronic mountain sickness: clinical aspects, etiology, management, and treatment[J]. High Alt Med Biol, 2016, 17(2): 61-69.
doi: 10.1089/ham.2016.0031
pmid: 27218284
|
| [2] |
León-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases[J]. High Alt Med Biol, 2005, 6(2): 147-157.
pmid: 16060849
|
| [3] |
Dong Y, Dun B, Wang Dui PB, et al. Therapeutic erythrocytapheresis is effective in treating high altitude polycythemia on the Qinghai-Tibet plateau[J]. Wilderness Environ Med, 2020, 31(4): 426-430.
doi: 10.1016/j.wem.2020.07.006
URL
|
| [4] |
Rombout-Sestrienkova E, Winkens B, van Kraaij M, et al. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naive hereditary hemochromatosis[J]. J Clin Apher, 2021, 36(3): 340-347.
doi: 10.1002/jca.21867
pmid: 33368569
|
| [5] |
何文华. 干扰素联合羟基脲治疗真性红细胞增多症的疗效观察[J]. 医药前沿, 2012, 2(9): 86.
|
| [6] |
Evers D, Kerkhoffs JL, Van Egmond L, et al. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis[J]. Transfus Apher Sci, 2013, 48(2): 187.
doi: 10.1016/j.transci.2013.02.030
pmid: 23809828
|
| [7] |
方洁, 李啸扬, 李军民, 等. 红细胞单采治疗高原红细胞增多症合并凝血功能异常的临床观察[J]. 实用心脑肺血管病杂志, 2019, 27(S2): 44-46.
|
| [8] |
朱澍, 罗布卓玛, 方洁, 等. 西藏地区红细胞单采治疗高原红细胞增多症的疗效研究[J]. 重庆医学, 2021, 50(3): 454-457.
|
| [9] |
Rombout-Sestrienkova E, Nieman FH, Essers BA, et al. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial[J]. Transfusion, 2012, 52(3): 470-477.
doi: 10.1111/j.1537-2995.2011.03292.x
pmid: 21848963
|
| [10] |
Jefferson JA, Escudero E, Hurtado ME, et al. Hyperuricemia,hypertension, and proteinuria associated with high-altitude polycythemia[J]. Am J Kidney Dis, 2002, 39(6): 1135-1142.
pmid: 12046023
|
| [11] |
McCord JM. Oxygen-derived free radicals in postischemic tissue injury[J]. N Engl J Med, 1985, 312(3): 159-163.
doi: 10.1056/NEJM198501173120305
URL
|
| [12] |
Roch-Ramel F, Guisan B, Diezi J. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles[J]. J Pharmacol Exp Ther, 1997, 280(2): 839-845.
pmid: 9023298
|
| [13] |
王琰, 努尔曼古丽, 王引虎, 等. 进驻不同海拔高原健康男青年肾功能的变化[J]. 西南国防医药, 2011, 21(1): 24-26.
|
| [14] |
Yang M, Cui S, Wuren T, et al. Ureteral calculi associated with high-altitude polycythemia[J]. Medicine (Baltimore), 2021, 100(7): e24621.
doi: 10.1097/MD.0000000000024621
URL
|
| [15] |
Hao Y, Reyes LT, Morris R, et al. Changes of protein levels in human urine reflect the dysregulation of signaling pathways of chronic kidney disease and its complications[J]. Sci Rep, 2020, 10(1): 20743.
doi: 10.1038/s41598-020-77916-z
URL
|
| [16] |
Vargas-Santos AB, Neogi T. Management of gout and hyperuricemia in CKD[J]. Am J Kidney Dis, 2017, 70(3): 422-439.
doi: S0272-6386(17)30579-6
pmid: 28456346
|
